Statements (29)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:dexamethasone
|
| gptkbp:ATCCode |
gptkb:S01BA01
|
| gptkbp:contraindication |
hypersensitivity to dexamethasone
advanced glaucoma aphakic eyes with ruptured posterior lens capsule ocular or periocular infections |
| gptkbp:duration |
up to 6 months
|
| gptkbp:form |
implant
intravitreal implant |
| https://www.w3.org/2000/01/rdf-schema#label |
Ozurdex
|
| gptkbp:indication |
gptkb:diabetic_macular_edema
non-infectious uveitis affecting the posterior segment of the eye macular edema following central retinal vein occlusion macular edema following branch retinal vein occlusion |
| gptkbp:manufacturer |
gptkb:Allergan
|
| gptkbp:mechanismOfAction |
corticosteroid anti-inflammatory
|
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:routeOfAdministration |
intravitreal
|
| gptkbp:sideEffect |
glaucoma
conjunctival hemorrhage eye pain increased intraocular pressure ocular hypertension |
| gptkbp:status |
FDA approved
EMA approved |
| gptkbp:storage |
store below 25°C
|
| gptkbp:bfsParent |
gptkb:dexamethasone
|
| gptkbp:bfsLayer |
5
|